Characteristic | Reported AIAA (N= 390) | P-value2 | |
---|---|---|---|
 | N | % |  |
Educational Level | Â | Â | 0.11 |
   High school or less | 29 | 42.0 |  |
   College or more | 169 | 52.7 |  |
Reasons for menopause | Â | Â | 0.13 |
   Natural | 98 | 47.6 |  |
   Induced | 91 | 55.5 |  |
Years since LMP | Â | Â | <.001 |
   <5 | 50 | 65.8 |  |
   5 to 10 | 63 | 60.6 |  |
   >10 | 83 | 40.7 |  |
Body mass index | Â | Â | 0.62 |
   <25 | 97 | 50.5 |  |
   25 to 30 | 68 | 45.3 |  |
   >30 | 68 | 49.3 |  |
Stage | Â | Â | 0.991 |
   0 and I | 75 | 50.4 |  |
   II | 102 | 51.0 |  |
   III | 21 | 51.2 |  |
Chemotherapy | Â | Â | 0.006 |
   None | 59 | 41.3 |  |
   Chemotherapy, but no Taxane | 49 | 50.2 |  |
   Chemotherapy included Taxane | 90 | 60.0 |  |
Aromatase inhibitors | Â | Â | 0.62 |
   Letrozole (Femara) | 33 | 46.5 |  |
   Anastrozole (Arimidex) | 119 | 49.4 |  |
   Exemestane (Aromasin) | 24 | 55.8 |  |
Years since start of AI 1 | Â | Â | 0.02 |
   <1 | 56 | 49.1 |  |
   1 to 3 | 67 | 59.6 |  |
   >3 | 55 | 41.7 |  |
Estrogen levels | Â | Â | Â |
   Detectable estradiol | 74 | 47.4 | 0.84 |
   Detectable estrone | 134 | 85.9 | 0.73 |